Seeing Is Believing

Currently out of the existing stock ratings of Sung Ji Nam, 140 are a BUY (91.5%), 13 are a HOLD (8.5%).
Analyst Sung Ji Nam, carries an average stock price target met ratio of 59.11% that have a potential upside of 28.67% achieved within 284 days. Previously, Sung Ji Nam worked at BTIG, CANTOR FITZGERALD, AVONDALE.
Sung Ji Nam’s has documented 320 price targets and ratings displayed on 30 stocks. The coverage was on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on CSTL, Castle Biosciences at 04-Nov-2025.
Analyst best performing recommendations are on GNMK (GENMARK DIAGNOSTICS).
The best stock recommendation documented was for VCYT (VERACYTE) at 11/4/2020. The price target of $42 was fulfilled within 1 day with a profit of $1.97 (4.92%) receiving and performance score of 49.21.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Aug-2021
$35
$7.28 (26.26%)
$27
1 months 25 days ago
(10-Aug-2026)
6/10 (60%)
$10.14 (40.79%)
208
Buy Since 15-Jun-2026
$27
$-0.72 (-2.60%)
$26
1 months 29 days ago
(06-Aug-2026)
2/2 (100%)
$4.9 (22.17%)
43
Buy Since 23-Nov-2020
$32
$4.28 (15.44%)
3 months 10 days ago
(25-Jun-2026)
2/5 (40%)
$11.96 (59.68%)
44
Buy Since 23-Nov-2020
$40
$12.28 (44.30%)
$60
1 years 4 months 14 days ago
(21-May-2025)
1/5 (20%)
$32.1 (406.33%)
49
Hold Since 18-Nov-2021
4 years 4 months 23 days ago
(12-May-2022)
1/2 (50%)
$47.4 (10.47%)
38